Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage

Masahiro Nezu1, Tomokazu Souma2, Lei Yu3

  • 1Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan; Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan; Division of Oxygen Biology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University Graduate School of Medicine, Sendai, Japan.

Kidney International
|October 30, 2016
PubMed

Insights

Activating Nrf2 in kidney tubules protects against oxidative stress and damage during acute kidney injury. This targeted approach may prevent the transition from acute kidney injury to chronic kidney disease.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Oxidative Stress Research

Background:

  • Acute kidney injury (AKI) is a severe condition with high morbidity, often leading to chronic kidney disease (CKD).
  • Ischemia-reperfusion injury (IRI) is a key mechanism in AKI, causing oxidative stress and organ damage.
  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a crucial transcription factor regulating cellular antioxidant responses.

Purpose of the Study:

  • To investigate the role of Nrf2 in IRI-induced kidney damage using genetic and pharmacological methods.
  • To determine if activating Nrf2 in specific kidney cell types can mitigate IRI-induced damage.
  • To explore Nrf2's potential as a therapeutic target for preventing AKI progression to CKD.

Main Methods:

  • Utilized global and tubular-specific Nrf2 activation in mouse models of IRI.
  • Administered the Nrf2 inducer CDDO during the acute phase of injury.
  • Assessed gene expression of antioxidant and NADPH synthesis enzymes (e.g., glucose-6-phosphate dehydrogenase).
  • Evaluated tubular damage in the outer medulla and cortex.
  • Tested CDDO efficacy on human proximal tubular cells (HK-2) and the impact of glucose-6-phosphate dehydrogenase knockdown.

Main Results:

  • Global and tubular Nrf2 activation enhanced antioxidant and NADPH synthesis, reducing outer medulla injury and cortical tubular damage.
  • Myeloid-specific Nrf2 activation showed no protective effect.
  • Short-term CDDO administration during initial injury ameliorated later tubular damage.
  • CDDO protected HK-2 cells from oxidative stress; G6PD knockdown increased reactive oxygen species.

Conclusions:

  • Tubular Nrf2 hyperactivation in early IRI phases prevents reactive oxygen species-mediated damage by boosting antioxidant enzymes and NADPH synthesis.
  • Nrf2 activation in kidney tubules is a promising strategy to prevent AKI progression to CKD.
  • Targeting tubular Nrf2 may offer a novel therapeutic avenue for AKI patients.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
441
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K